|
ENVB Enveric Biosciences Inc 890821 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-1,633,473.00 |
| Balance Sheet |
|
Current Assets
|
$5,375,099.00 |
|
Assets
|
$5,521,464.00 |
|
Current Liabilities
|
$460,676.00 |
|
Equity
|
$5,060,788.00 |
|
Shares Out
|
1887535.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,256,839.00 |
|
Investing Cash Flow
|
$11,667.00 |
| Market Analysis |
Market Cap
|
$2,699,175.05 |
|
Price
|
$1.60 |
|
BVPS
|
2.68 |
|
PB
|
0.53 |
|
EPS
|
-1.08 |
|
FCF
|
$-2,262,019.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ENVB documents filed with the SEC.
ENVB Filings
Clear
